Trial
NCT02654314
Prevention of Delirium in Inpatients Utilizing Melatonin
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
—
Condition
Delirium
Intervention
Melatonin
Why stopped
Lack of resources to complete the study. Descriptive statistics for the outcome measures collected are provided.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-21